4//SEC Filing
Tessier Maude 4
Accession 0000899243-22-002657
CIK 0001835579other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 4:30 PM ET
Size
14.7 KB
Accession
0000899243-22-002657
Insider Transaction Report
Form 4
Tessier Maude
Chief Business Officer
Transactions
- Exercise/Conversion
Common Stock
2022-01-18$4.51/sh+8,265$37,275→ 100,578 total - Exercise/Conversion
Common Stock
2022-01-18$4.15/sh+24,606$102,115→ 92,313 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-01-18−38,915→ 5,560 totalExercise: $2.94Exp: 2028-08-08→ Common Stock (38,915 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2022-01-18−8,265→ 28,963 totalExercise: $4.51Exp: 2029-12-05→ Common Stock (8,265 underlying) - Exercise/Conversion
Common Stock
2022-01-18$2.94/sh+38,915$114,410→ 67,707 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-01-18−24,606→ 11,186 totalExercise: $4.15Exp: 2029-03-19→ Common Stock (24,606 underlying)
Footnotes (3)
- [F1]25% of this option vested and became exercisable on July 16, 2019, with the remainder vesting in 36 substantially equal monthly installments thereafter.
- [F2]25% of this option vested and became exercisable on March 20, 2020, with the remainder vesting in 36 substantially equal monthly installments thereafter.
- [F3]25% of this option vested and became exercisable on December 6, 2020, with the remainder vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Ikena Oncology, Inc.
CIK 0001835579
Entity typeother
Related Parties
1- filerCIK 0001848534
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 4:30 PM ET
- Size
- 14.7 KB